Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

Diagnosis, prognosis and management of incidentally found prostate cancer


Incidentally discovered cancer of the prostate may be divided into focal and diffuse disease. The focal tumour tends to be of low grade and low-volume and in the majority of patients runs a clinically benign course. In 10–15% of untreated patients, however, progression occurs by 10 years after diagnosis. At the same stage of follow-up 30–63% of the patients have died of other causes, with no evidence of recurrence. In patients with low-grade focal cancer of the prostate, radical prostatectomy may be curative. An alternative management option is to closely observe these patients. Digital rectal examination, prostatic specific antigen, transrectal prostatic ultrasound and repeated prostatic biopsies can all make contributions to the follow-up of these patients.

This is a preview of subscription content, log in to check access.


  1. 1.

    Adolfsson J, Ronstrom L, Hedlund P, Lowhagen T, Carstensen J, Tribukait B (1990) The prognostic value of modal deoxyribonucleic acid in low grade, low stage untreated prostate cancer. J Urol 144:1404

  2. 2.

    Adolfsson J, Tribukait B (1990) Evaluation of tumour progression by repeated fine needle biopsies in prostate adenocarcinoma: modal deoxyribonucleic acid value and cytological differentiation. J Urol 144:1408

  3. 3.

    Blute M, Zincke H, Farrow GM (1986) Long-term follow-up of young patients with stage A adenocarcinoma of the prostate. J Urol 136:840

  4. 4.

    Brawn PN (1983) The dedifferentiation of prostate carcinoma. Cancer 52:246

  5. 5.

    Bridges CH, Belville WD, Insalaco SJ, Buck AS (1983) Stage A prostatic carcinoma and repeat transurethral resection: a reappraisal 5 years later. J Urol 120:307

  6. 6.

    Byar DP and The Veterans Administration Cooperative Urological Research Group (1972) Survival of patients with incidentally found microscopic cancer of the prostate: results of a clinical trial of conservative treatment. J Urol 108:908

  7. 7.

    Byar DP, Corle DK and The Veterans Administration Cooperative Urological Research Group (1981) VACURG randomised trial of radical prostatectomy for stages 1 and 2 prostate cancer. Urology 17 [Suppl] 7

  8. 8.

    Carroll PR, Leitner TC, Yen B, Watson RA, Williams RD (1985) Incidental carcinoma of the prostate: significance of staging transurethral resection. J Urol 133:811

  9. 9.

    Carter HB, Partin AW, Epstein JI, Chan DW, Walsh PC (1990) The relationship of prostate specific antigen levels and residual tumour volume in stage A prostate cancer. J Urol 144:1167

  10. 10.

    Carter HB, Piantadosi S, Isaacs JT (1990) Clinical evidence for and implications of the multistep development of prostate cancer. J Urol 143:742

  11. 11.

    Correa RJ, Anderson RG, Gibbons RP, Mason JT (1974) Latent carcinoma of the prostate: why the controversy? J Urol 111:644

  12. 12.

    Cumming JA, Ritchie AWS, Goodman CM, McIntyre MA, Chisholm GD (1990) Dedifferentiation with time in prostate cancer and the influence of treatment on the course of the disease. Br J Urol 65:271

  13. 13.

    Denton SE, Choy SH, Valk WL (1965) Occult prostatic carcinoma diagnosed by the step section technique of the surgical specimen. J Urol 93:296

  14. 14.

    Donohue RE, Mani JH, Whitesel JA et al. (1982) Pelvic lymph node dissection: guide to patient management in clinically locally confined adenocarcinoma of the prostate. Urology 20:559

  15. 15.

    Egawa S, Greene DR, Flanagan WF, Wheeler TM, Scardino PT (1991) Transurethral ultrasonography in stage A prostate cancer: detection of residual tumour after transurethral resection of the prostate. J Urol 146:366

  16. 16.

    Epstein JI, Oesterling JE, Walsh PC (1988) The volume and anatomical location of residual tumour in radical prostatectomy specimens removed for stage A1 prostate cancer. J Urol 139:975

  17. 17.

    Epstein JI, Paull G, Eggelston JC, Walsh PC (1986) Prognosis of untreated stage A1 prostatic carcinoma: a study of 94 cases with extended follow-up. J Urol 136:837

  18. 18.

    Greene DR, Egawa S, Neerhut G, Flanagan TM, Wheeler TM, Scardino PT (1991) The distribution of residual cancer in radical prostatectomy specimens in stage A prostatic cancer. J Urol 145:324

  19. 19.

    Hanash KA, Utz DC, Cook EN, Taylor WF, Titus JL (1972) Carcinoma of the prostate: a 15 year follow-up. J Urol 107:450

  20. 20.

    Heaney JA, Chang HC, Daly JJ, Prout GR Jr (1977) Prognosis of clinically undiagosed prostatic carcinoma and the influence of endocrine therapy. J Urol 118:283

  21. 21.

    Hodge KK, McNeal JE, Stamey TA (1989) Ultrasound guided transrectal core biopsies of the palpably abnormal prostate. J Urol 142:66

  22. 22.

    Hodge KK, McNeal JE, Terris MK, Stamey TA (1989) Random systematic versus directed ultrasound guided transrectal core biopsies of the prostate. J Urol 142:71

  23. 23.

    Hudson MA, Bahnson RA, Catalona WJ (1989) Clinical use of prostate specific antigen in patients with prostate cancer. J Urol 142:1011

  24. 24.

    Humphrey P, Vollmer RT (1988) The ratio of prostate chips with cancer: a new measure of tumour extent and its relationship to grade and prognosis. Hum Pathol 19:411

  25. 25.

    Jewett HJ (1975) The present status of radical prostatectomy for stages A and B prostatic cancer. Urol Clin North Am 2:105

  26. 26.

    Kaplan ID, Bagshaw MA, Cox CA, Cox RS (1991) Radiotherapy for incidental adenocarcinoma of the prostate. In: Altwein JE, Faul P, Schneider W (eds) Incidental carcinoma of the prostate. Springer, Berlin Heidelberg New York, p 167

  27. 27.

    Larsen MP, Carter HB, Epstein JI (1991) Can stage A1 tumour extent be predicted by transurethral resection tumour volume, percent or grade? A study of 64 stage A1 radical prostatectomies with comparison to prostates removed for stages A2 and B disease. J Urol 146:1059

  28. 28.

    Lehman TH, Kirchheim D, Braun E, Moore R (1968) An evaluation of radical prostatectomy for incidentally diagnosed carcinoma of the prostate. J Urol 99:646

  29. 29.

    Lowe BA, Listrom MB (1988) Incidental carcinoma of the prostate: an analysis of the predictors of progression. J Urol 140:1340

  30. 30.

    McIntyre TL, Murphy WM, Coon JS et al. (1988) The prognositic value of DNA ploidy combined with histologic substaging for incidental carcinoma of the prostate gland. Am J Clin Pathol 89:370

  31. 31.

    McNeal JE, Bostwick DG, Kindrachuk RA, Redwine EA, Freiha FS, Stamey TA (1986) Patterns of progression in prostate cancer. Lancet I:60

  32. 32.

    McNeal JE, Price HM, Redwine EA, Freiha FS, Stamey TA (1988) Stage A versus stage B adenocarcinoma of the prostate: morphological comparison and biological significance. J Urol 139:61

  33. 33.

    Moore GH, Lawshe B, Murphy J (1986) Diagnosis of adenocarcinoma in transurethral resectates of the prostate gland. Am J Surg Pathol 10:165

  34. 34.

    Morton RA, Steiner MS, Walsh PC (1991) Cancer control following anatomical radical prostatectomy: an interim report. J Urol 145:1197

  35. 35.

    Mostofi FK (1986) Prostate sampling. Am J Surg Pathol 10:175

  36. 36.

    Murphy WM, Dean PJ, Brasfield JA, Tatum L (1986) Incidental carcinoma of the prostate: how much sampling is adequate? Am J Surg Pathol 10:170

  37. 37.

    Parfitt HE, Smith JA, Gleidman JB, Middelton RG (1983) Accuracy of staging in A1 carcinoma of the prostate. Cancer 51:2346

  38. 38.

    Parra RO, Gregory JG (1989) Transrectal ultrasound in stage A1 prostate carcinoma. Urology 34:344

  39. 39.

    Paulson DF (1991) Does detection of small-volume prostatic adenocarcinoma by ultrasound or magnetic resonance imaging provide improvement in disease control? In: Altwein JE, Faul P, Schneider W (eds) Incidental carcinoma of the prostate. Springer, Berlin Heidelberg New York, p 140

  40. 40.

    Paulson DF, Robertson JE, Daubert LM, Walther PJ (1988) Radical prostatectomy in stage A prostatic adenocarcinoma. J Urol 140:535

  41. 41.

    Roy CR, Horne D, Raife M, Pienkos E (1990) Incidental carcinoma of the prostate: long term follow-up. Urology 36:210

  42. 42.

    Schmidt JD, Mettlin CJ, Natarajan N et al. (1986) Trends in patterns of care for prostatic cancer, 1974–1983: results of surveys by the American College of Surgeons. J Urol 136:416

  43. 43.

    Schroeder FH, Blom JHM, Hop WCJ, Mostofi FK (1983) Incidental carcinoma of the prostate treated by total prostatectomy: the prognostic impact of microscopic tumour extension and grade. World J Urol 1:15

  44. 44.

    Schroeder FH, Hermaneck P, Denis L, Fair WR (1992) The TNM classification of prostate cancer. Prostate [Suppl 4]:129

  45. 45.

    Sheldon CA, Williams RD, Fraley EE (1980) Incidental carcinoma of the prostate: a review of the literature and critical reappraisal of classification. J Urol 124:626

  46. 46.

    Silverberg E, Boring CC, Squires TS (1990) Cancer statistics, 1990. CA 40:9

  47. 47.

    Silverberg E, Lubera JA (1986) A review of the American Cancer Society: estimates of cancer cases and deaths. CA 36:9

  48. 48.

    Stamey TA, Kabalin JN, McNeal JE et al. (1989) Prostate specific antigen in the diagnosis and treatment of adenocarcinoma of the prostate. II. Radical prostatectomy treated patients. J Urol 141:1076

  49. 49.

    Svanholm H, Starklint H, Barlebo H, Olsen S (1990) Histological evaluation of prostatic cancer. III. Reproducibility of assessment of tumour volume and its possible significance for prognosis. APMIS 98:237

  50. 50.

    Terris MK, McNeal JE, Stamey TA (1992) Transrectal ultrasound imaging and ultrasound guided biopsies in the detection of residual carcinoma in clinical stage A carcinoma of the prostate. J Urol 147:864

  51. 51.

    Thompson IA, Zeidman EJ (1989) Extented follow-up of stage A1 carcinoma of the prostate. Urology 33:455

  52. 52.

    Vallancien G, Prapotnich D, Veillon B, Brisset JM, Andre-Bougaran J (1991) Systematic prostatic biopsies in 100 men with no suspicion of cancer on digital rectal examination. J Urol 146:1308

  53. 53.

    Vicente J, Chechile G, Algaba F (1989) The role of repeat transurethral resection in stage A1 carcinoma of the prostate. Eur Urol 16:325

  54. 54.

    Voges GE, McNeal JE, Redwine EA, Freiha FS, Stamey TA (1992) The predictive significance of substaging stage A prostate cancer (A1 versus A2) for volume and grade of total cancer in the prostate. J Urol 147:858

  55. 55.

    Vollmer RT (1986) Prostate cancer and chip specimens: complete versus partial sampling. Hum Pathol 17:285

  56. 56.

    Whitmore WF Jr (1956) Symposium on hormones and cancer therapy: hormone therapy in prostatic cancer. Am J Med 21:697

  57. 57.

    Whitmore WF (1990) Natural history of low-stage prostatic cancer and the impact of early detection. Urol Clin North Am 17:689

  58. 58.

    Yamabe H, ten Kate FJW, Gallee MPW et al. (1986) Stage A prostate cancer: a comparative study in Japan and the Netherlands. World J Urol 4:136

  59. 59.

    Zhang G, Wasserman NF, Sidi AA, Reinberg Y, Reddy PK (1991) Long-term follow-up results after expectant management of stage A1 prostatic cancer. J Urol 146:99

  60. 60.

    Zincke H, Blute ML, Fallen MJ, Farrow GM (1991) Radical prostatectomy for stage A adenocarcinoma of the prostate: staging errors and their implications for treatment recommendations and disease outcome. J Urol 146:1053

Download references

Author information

Correspondence to P. J. T. Davidson.

Rights and permissions

Reprints and Permissions

About this article

Cite this article

Davidson, P.J.T. Diagnosis, prognosis and management of incidentally found prostate cancer. Urol. Res. 21, 1–8 (1993).

Download citation

Key words

  • Prostate
  • Cancer
  • Incidental
  • Al